HOME Research Insight Product Development and Commercialization are the Key Strategies Adopted by Market Players to Foster their Growth in the Global Bone Growth Stimulators Market



Product Development and Commercialization are the Key Strategies Adopted by Market Players to Foster their Growth in the Global Bone Growth Stimulators Market


The key players focused on various strategies such as product launches and enhancements; agreements & partnerships; strategic acquisitions; and market expansions to increase their shares in the global bone growth stimulators market. Product launches & geographical expansions are the strategy adopted by major industry players to achieve desired market growth during 2013–2017. This strategy was adopted by Orthofix International N.V. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Isto Biologics (U.S.). Apart from product launches & expansions, prominent players also adopted mergers & acquisitions, partnerships, agreements and collaborations as their key growth strategies to strengthen their market presence.

Orthofix International N.V. held the leading position in the market in 2016. The company offers its non-invasive bone growth stimulators through its BioStim business segment. It has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific, and other countries. Orthofix has a strong geographic presence in 65 countries including in the U.S., the U.K., Italy, Germany, Switzerland, Austria, France, Brazil, Australia, and Puerto Rico. The company is primarily focused on product development/commercialization and collaborations as its key growth strategies to withhold its leading market position in the bone growth stimulators industry. In line with this, during 2014-2017, the company collaborated with leading clinical organizations such as Musculoskeletal Transplant Foundation (U.S.), the Orthopedic Research and Education Foundation (U.S.), and the Texas Scottish Rite Hospital for Children (U.S.) to strengthen its product development and manufacturing capabilities in the bone growth stimulators market.

Medtronic plc is one of the prominent players in the bone growth stimulators market. The company has a strong foothold in the market and offers its bone morphogenetic protein-Infuse. The company has a strong geographic presence across Asia-Pacific, Eastern Europe, Latin America, the Middle East & Africa, Central Asia, Western Europe, South Asia, and North America. To strengthen its current position and to gain a larger share of the market, the company has aggressively focused on market expansions during 2014-2017. For instance, in May 2016, Medtronic plc established its Asia-Pacific regional headquarters in Singapore.

Related Reports:

Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports